Endometrial Mucinous Adenocarcinoma, also known as uterine corpus mucinous adenocarcinoma, is related to endometrial adenocarcinoma and adenocarcinoma in situ. An important gene associated with Endometrial Mucinous Adenocarcinoma is MUC6 (Mucin 6, Oligomeric Mucus/Gel-Forming), and among its related pathways/superpathways are G-Beta Gamma Signaling and Fragile X syndrome. The drugs Nintedanib and Ipilimumab have been mentioned in the context of this disorder. Affiliated tissues include endothelial, and related phenotypes are neoplasm and muscle